Check here the status of your abstract
Home Page
Invitation
Executive board
Committee
Programme at a glance
Scientific Programme
Scientific Information
Registration Information
General Information
Social Events
Accommodation Information
Acnowledgements
Welcome to Lisbon
Excursion and Tours
Excursion Registration Form
Forms
Links
SCIENTIFIC PROGRAMME
   
SATURDAY | SUNDAY | MONDAY | TUESDAY | WEDNESDAY | LECTURES |
   

SATURDAY, JUNE 24, 2006 - HALL A

OPENING CEREMONY

18.00

Welcome Address
J. Fernandes e Fernandes (Portugal)

Lecture
Historical Perspective of the International Union of Angiology
P. Balas (Greece)

Lecture
The Surgeon Scientist - An Endangered Species

J. Lobo Antunes (Portugal)

Presidential Lecture
The International Union of Angiology: An International and Multinational Society between
Tradition and Innovation

S. Novo (Italy)

19.30

Welcome Cocktail

Top
   

SUNDAY, JUNE 25, 2006 - HALL A

PLENARY SESSION

8.30 - 9.00

Lecture
The 1st Joao Cid Dos Santos Lecture
Sir Peter Bell (UK)

9.00 - 11.00

Management of Chronic Venous Disease: A Consensus Meeting
Chairmen: C. Allegra (Italy), A.N. Nicolaides (Cyprus)

Pathophysiology and Implications for Therapy
A.N. Nicolaides (Cyprus)

CEAP Classification and Implications for Investigation
B. Eklof (Sweden)

Review of Compression and Pharmacological Therapy
A.A. Ramelet (Switzerland)

Radiofrequency, Laser and Foam: Selection of Patients
M. Perrin (France)

The Changing Practice of Surgery: Superficial, Perforator, and Deep Veins
J. Bergan (USA)

Assessment of Efficacy of Therapies
E. Rabe (Germany)

In co operation with SERVIER

11.00 - 11.30 BREAK AND VISIT OF THE EXHIBITION

11.30 - 13.00

International Venous Forum: Chronic Venous Disease
Chairmen: P. Gloviczki (USA), M. De Castro Silva (Brazil), C. Allegra (Italy)
Moderator: J. Caprini (USA), A. Comerota (USA)

Venous Hemodynamics Glossary
P. Coleridge-Smith (UK)

Microcirculatory Disturbances and Venous Ulceration
C. Allegra (Italy)

Hormone Replacement Therapy and Venous Disease
M.E. Renno de Castro Santos (Brazil)

Ovarian Vein Incompetence
J.T. Hobbs (UK)

Combined Surgery and Laser Therapy for Chronic Venous Insufficiency
R. Simkin (Argentina)

Perforating Veins: Their Significance and Current Management
P. Gloviczki (USA)

Reconstructive for Deep Vein Reflux in the Lower Limb
M. Perrin (France)

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.00 - 16.00

New Developments for the Management of Carotid Disease
Chairmen: G. Biasi (Italy), C. Liapis (Greece), J.L. Nascimento Silva (Brazil)

Inflammation and Carotid Disease
C. Liapis (Greece)

Identification of the Active Carotid Plaque
L. Mendes Pedro (Portugal)

Magnetic Resonance Imaging for Carotid Bifurcation Disease
W. Paaske (Denmark)

Lessons from the Asymptomatic Trials
A.N. Nicolaides (Cyprus)

PTA/Stent for Carotid Disease: A Look Back, the Present and the Future
K. Mathias (Germany)

Endovascular Treatment for Carotid Bifurcation Disease
J.L. Nascimento Silva (Brazil)

Carotid Artery Surgery PTA/STENT - What Should be the Determinants of Choice?
D. Kiskinis (Greece)

Duplex-controlled PTA/Stent for Carotid Disease
E. Ascer (USA)

An invited Commentary
Sir Peter Bell (UK)

In co operation with BOSTON SCIENTIFIC

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00

Advances in Interventional Cardiovascular Procedures
Chairmen: H. Ehringer (Austria), S. Novo (Italy)
Moderator: L. Pathak (India)

Carotid Angioplasty and Stenting under Cerebral Protection: Indications and Results
M. Henry (France)

Carotid Artery Stenting: “Wallstent” Healing and Arterial Remodeling
H. Ehringer (Austria)

Primary PTCA: The Best Choice for all Patients with Acute Coronary Syndromes?
V. Cospite (Italy)

PTA/STENT: the First Option for Proximal Aorto-iliac Stenosing Disease?
J. Fernandes e Fernandes (Portugal)

Management of Visceral and Renal Artery Disease
A.T. Guillaumon (Brazil)

Role of Clopidogrel and IIb/IIa Inhibitors in Interventional Cardiology
J.J. Michiels (The Netherlands)

Assessment of Coronary Artery Disease - Role of Endovascular Ultrasound
F. Pinto (Portugal)

 

SUNDAY, JUNE 25, 2006 - HALL B

11.00 - 13.00

New Developments on Anti-Platelet Pharmacotherapy
Chairmen: L. Pathak (India), S. Harder (Germany), S. Mousa (USA), G. Rao (USA)

Introductory Overview
H.K. Breddin (Germany)

Aspirin, ADP Antagonists, GP IIb/IIIa Inhibitors and New Targets
W. Jeske (USA)

Progress in the Development of Newer ADP Receptor Inhibitors
W. Haque (Canada)

Clinical Trial with Clopidogrel
S. Harder (Germany)

Serotonin Antagonists in the Management of Arterial Thrombosis
H. Rieger (Germany)

Newer Antiplatelets Drugs
S. Mousa (USA)

Antiplatelet Drugs in Acute Coronary Syndrome
R. Wahi (USA)

Bleeding Complications Associated with Combined Antiplatelet Therapy
H. Messmore (USA)

In co operation with SANOFI AVENTIS

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.00 - 15.30

In Vivo Measurement of Elastic Compression
Chairmen: H. Partsch (Austria), S. Haas (Germany)

Measurement of Interface Pressure
M. Jünger (Germany)

Dynamic Stiffness Index
H.A.M. Neumann (The Netherlands)

Static Stiffness Index
H. Partsch (Austria)

Changes of Leg Volume under Different Compression Devices
G. Mosti, V. Mattaliano (Italy)

Compression in Lymphoedema
C. Moffatt (UK)

Clinical Pathway to Improve Cost Efficacy and Quality of Life for Venous Leg Ulcer Treatment
R. Polignano, A. Andriessen, M. Abel (The Netherlands)

In co operation with LOHMANN & RAUSCHER

15.30 - 16.00 Lecture

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00

New Developments and New Instrumentation for the Management of Varicose
Veins - Impact on Today’s Practice

Chairmen: J. Bergan (USA), M. Van den Driessche (Belgium)

Endo-laser and Venous Disease: Italian Group Experience
G.B. Agus (Italy)

The Impact of Endo-laser on Management of Venous Insufficiency
R. Simkin (Argentina)

Treatment of Primary Venous Insufficiency by Endovenous Obliteration with the VNUS.
Closure System. Results of a Long-term Multicenter Prospective
M. Perrin (France)

Endovenous Laser in the Treatment of Varicose Veins
C. Spartera (Italy)

Debate:
Is Conventional Open Surgery still the Gold Standard for Treatment of Varicose Veins?
For: J.T. Hobbs (UK)
Against: J. Bergan (USA)

 

SUNDAY, JUNE 25, 2006 - HALL C

11.30 - 13.00

Update in Compression Therapy: New Indications for “Old” Diseases
Chairman: J.D. Menezes (Portugal)

Which Compression after Traditional and Endovascular Surgery?
G.B. Agus (Italy)

Which Role of Compression for Prevention of DVT? Just in Place of or also in Association with Heparins?
C. Cimminiello (Italy)

“Made to measure” or “Made for disease” Stockings? Results of Anthropometrical Studies
G. Arpaia (Italy)

Compression after Surgery: European Attitudes
J.D. Menezes (Portugal)

In co operation with CIZETA MEDICALI

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.00 - 15.30

Argatroban: The First Clinical Direct Drug Thrombin Inhibitor.
A Tribute to Professor Okamoto

Chairmen: H.K. Breddin (Germany), J. Fernandes e Fernandes (Portugal)

Thrombin as a Target to Develop Newer Drugs to Manage Thrombosis
J. Fareed (USA)

Currently Available Antithrombin Agents and Their Use in Medical and Surgical Indications
J. Walenga (USA)

Argatroban in the Management of Heparin Induced Thrombocytopenia
B. Lewis (USA)

Argatroban in PCI
S. Harder (Germany)

Argatroban in the Management of Stroke: Related Disorders
G. Del Zoppo (USA), H. Shigematsu (Japan)

Mechanism of Action of Argatroban
M. Samama (France)

Argatroban Development from Bench to Bedside. A Tribute to Professor Okamoto
M. Osakabe (Japan)

15.30 - 16.00 Lecture

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00

Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/MLAVS MEDITERRANEAN LEAGUE OF ANGIOLOGY AND VASCULAR SURGERY

Multidisciplinary Approach for the Treatment of Peripheral and Renal Arterial Disease
Chairmen: N. Angelides (Cyprus), S. Novo (Italy)

Peripheral and Renal Occlusive Arterial Disease: Statistics and Conservative Treatment
A. Schirger (USA)

Supervised Exercise and Modification of Risk Factors
N. Angelides (Cyprus)

Statins in Vascular Patients: Effects on Perioperative Morbitity and Mortality
D. Mikhailidis (UK)

Arterial Occlusive Disease Proximal and Distal to the Inguinal Ligament: The Endovascular Option
J. Pisco (Portugal)

Arterial Occlusive Disease Proximal and Distal to the Inguinal Ligament: The Surgical Option
C. Liapis (Greece)

Is Renal Angioplasty a Cosmetic or Real Intervention?
P. Polydorou (Greece)

 

 

SUNDAY, JUNE 25, 2006 - HALL D

11.30 - 13.00
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/VAS VASCULAR INDEPENDENT RESEARCH AND EDUCATION - EUROPEAN ORGANIZATION

Diabetes and Cardiovascular Disease
Organized by M. Catalano

Programme to be defined

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.00 - 15.30
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/SFMV SOCIÉTÉ FRANÇAISE DE MÉDECINE VASCULAIRE

Cellular Therapy in Critical Limb Ischemia
Chairmen: G. Pernod (France), M.A. Sevestre (France)
Moderator: S. Mousa (USA)

What is Therapeutic Angiogenesis?
R. Pola (Italy)

What Cell do we Choose?
G. Pernod (France)

Specific Features of Patients Treated with Cell Therapy in Critical Limb Ischemia
M.A. Sevestre (France)

Cell Therapy in Critical Limb Ischemia: An Overview of the Trials
D. Stephan (France)

15.30 - 16.00 Lecture

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/LAVF LATIN AMERICAN VENOUS FORUM

New Advances in Phlebology
Presidents: M. Castro Silva (Brazil), E. Renno de Castro Santos (Brazil)
Chairmen: R. Simkin (Argentina), J. Ulloa (Colombia)

Cosmetic Approach for Varicose Veins Surgery
P. Komlos (Brazil)

Endovascular Occlusion Foam in the Treatment of Chronic Venous Disease
J. Ulloa Jr., J. Ulloa (Colombia)

Combined Surgery, with Endovenous Laser, Muller Technique and Videoscopy
R. Simkin, R. Bulloj, C.G. Simkin (Argentina)

Treatment of Varicose Veins with Foam - Personal Experience
M. Figueiredo (Brazil)

Is Endoluminal Laser Varicose Veins Surgery Exclusive for Great Saphenous Veins?
C. Carmelino (Peru)

Total Foam Sclerotherapy in the Bloodless Field
M. Trinidad (Mexico)

 

SUNDAY, JUNE 25, 2006 - HALL E

11.30 - 13.00

An Update on Defibrotide as Anticoagulant and Anti-ischemic Drug
Chairmen: A. Strano (Italy), S. Coccheri (Italy)
Moderator: O. Ulutin (Turkey)

Historic Perspective and the Clinical Development of Defibrotide
S. Coccheri (Italy)

Defibrotide in the Management of Arterial Thrombosis
A. Strano (Italy), S. Novo (Italy)

Defibrotide in the Management of Venous Thrombosis
M. Lassen (USA)

Pharmacologic Rationale
J. Fareed (USA)

Novel Observations on the Mechanism of Action of Defibrotide
G. Eisner (USA)

Expanded Indications of Defibrotide
M. Iacobelli (Italy)

Invited Discussion
H.K. Breddin (Germany)

14.00 - 15.00

Canadian Cardiovascular Society Consensus Conference: Peripheral Arterial Disease;
Executive Summary

B. Abramson, V. Huckell (Canada)

 

SUNDAY, JUNE 25, 2006 - HALL F

11.30 - 18.00 Oral Communications

 
Top

MONDAY, JUNE 26, 2006 - HALL A

PLENARY SESSION

8.30 - 9.00

Lecture
The 1st Panagiotis Balas Lecture
G. Biasi (Italy)

9.00 - 11.00

Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/MAYO CLINIC (USA) - PART I

Optimal Management of Aortic Aneurysmal Disease
President: A. Medina (Brazil)
Chairmen: P. Gloviczki (USA), R. Greenhalgh (UK), V. Riambau (Spain)
Moderator: P. Kalman (USA)

Abdominal Aortic Aneurysms: Optimal Management at Mayo Clinic
P. Gloviczki (USA)

Endovascular versus Conventional Surgery - The EVAR Trials and Implications for Management
R. Greenhalgh (UK)

Determinants for Success and Failure for Endovascular Repair of AAA
G. Biasi (Italy)

EVAR versus Open Repair - Analysis of 1,000 AAA
P. Polterauer (Austria)

Impact of Fenestrated Endografts for AAA Management
E. Verhoeven (The Netherlands)

11.00 - 11.30 BREAK AND VISIT OF THE EXHIBITION

11.30 - 13.00

INTERNATIONAL UNION OF ANGIOLOGY/MAYO CLINIC (USA) - PART II

Endovascular Treatment for Thoracic and Abdominal AAA - A report from Brazil
A. Von Ristow (Brazil)

Management of Thoracic Aneurysms - Will Endovascular Treatment Replace Conventional Surgery?
V. Riambau (Spain)

Complex Aortic Arch Aneurysms - Are the Hybrid Procedures Improvements?
P. Bergeron (France)

Hybrid Procedures for Complex Thoraco-abdominal Aneurysms - An Improvement?
J. Wolfe (UK)

Repair of Thoraco-abdominal Aneurysms - What Should be Expected?
H. Safi (USA)

Ruptured AAA: Is Endovascular Repair an Alternative?
F. Veith (USA)

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.00 - 15.45
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/LOYOLA UNIVERSITY (USA)

New Anticoagulant Agents - Impact on the Future Management of Cardiovascular Patients
Chairmen: R.L. Bick (USA), J. Walenga (USA)

Development of New Anticoagulant Drugs - Are we on the Right Track?
J. Fareed (USA)

Anti-thrombin Agents. Development of Argatroban as the First Antithrombin Agent
M. Osakabe (Japan)

Anti-Xa Drugs
B. Kaiser (Germany)

Heparin derived Oligosaccharides
J. Walenga (USA)

Bioheparins as Potential Replacements of Heparins
U. Cornelli (Italy)

Dual Acting Anticoagulants
W. Haque (Canada)

Recombinant Protein Equivalent of Antithrombotics of Natural Origin (Thrombomodulin, Diannexin)
D. Hoppensteadt (USA)

Invited Discussion
H.K. Breddin (Germany), R. Wahi (USA)

15.45 - 16.00 Lecture

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00

Anti Xa Agents in the Management of Thrombosis
Chairmen: B. Kaiser (Germany), M. Lassen (Denmark)

From Heparin to Pentasaccharide. Validation of the Anti-Xa Concept as a Potential Target to Develop New Antithrombotic Drugs
J. Walenga (USA)

Synthetic Pentasaccharide Anti-Xa Drugs
M. Samama (France)

Synthetic Oral Anti-Xa Agents
D. Hoppensteadt (USA)

Ongoing Clinical Trials on Anti-Xa Agents
S. Haas (Germany)

Combined Anti-Xa and Anti-IIa Drugs
J. Fareed (USA)

Anti-Xa versus Anti-IIa Drugs
M. Lassen (Denmark)

Will Anti-Xa Drugs Replace Heparins and Oral Anticoagulants?
S. Harder (Germany), B. Kaiser (Germany)

In co operation with SANOFI AVENTIS

MONDAY, JUNE 26, 2006 - HALL B

11.00 - 12.00
Satellite Symposium

PIERRE FABRE MEDICAMENT

Clinical Management of CVD: Relevance of Venous Microangiopathy in Everyday Practice
Chairman: P. Carpentier (France)

Physiopathology and Clinical Aspects from Macro to Microcirculation in CVD
A.N. Nicolaides (Cyprus)

Physiopathology and Pharmacological Targets in CVD
E. Bouskela (Brazil)

Clinical Evaluation of CVD and Therapeutic Applications
P. Carpentier (France)

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.30 - 16.00
Satellite Symposium

SANOFI AVENTIS

Optimizing VTE Management in 2006 - Current Evidence and Future Prospects
Chairmen: M. Samama (France), A.J. Kakkar (UK)
Moderator: J. Fareed (USA)

VTE - The Scope of the Disease
A. Cohen (USA)

Optimizing VTE Management - Key Highlights of IUA Guidelines 2006
A. Spyropoulos (USA)

Differentiation among Antithrombotic Agents - The case of LMWHs
W. Jeske (USA)

LMWHs beyond Anticoagulant Effects - The OVANOX Trial
A.J. Kakkar (UK)

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00

New Challenges in the Management of Acute Stroke and the Role of Stroke Units
Chairmen: J. Ferro (Portugal), G. Del Zoppo (USA)
Moderator: J. Biller (USA)

Current Concepts in the Diagnosis and Management of Stroke
J. Biller (USA)

Hemorrhagic Stroke
J. Biller (USA)

Management of Thrombotic and Ischemic Stroke
G. Del Zoppo (USA)

Invited Discussion
Stroke Units and the Role of the Vascular Surgeon
W. Sandmann (Germany)

MONDAY, JUNE 26, 2006 - HALL C

11.30 - 13.00

Intermittent Claudication: Awareness, Treatment and Cardiovascular Risk
Chairmen: G.M. Andreozzi (Italy), J. Fernandes e Fernandes (Portugal)

I.C. Unknown and Untreated Disease: The Tip of the Iceberg
G. Brevetti (Italy)

I.C. - The Actual Strategy of Treatment
K. Roztocil (Czech Republic)

I.C. as Marker of Cardiovascular Risk: How to Reduce it?
G. Gensini (Italy)

I.C. Consensus on the Management: An Incoming Document from Central European Vascular Forum
G.M. Andreozzi (Italy)

In co operation with BIOFUTURA PHARMA

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.00 - 15.30

Foam Sclerotherapy, a Reappraisal
Chairmen: G. Geroulakos (UK), E. Kalodiki (UK)

Properties of Foam Sclerotherapy
A. Frullini (Italy)

Ultrasound Sclerotherapy Combined with Saphenofemoral Ligation Compared to Surgical Treatment of Varicose Veins
D. Boudouroglou (UK)

Evaluation of the Efficacy of Foam Compared with Liquid in the Sclerotherapy of the Greater Saphenous Vein
C. Hamel-Desnos (France)

How to Avoid Complications of Foam Sclerotherapy in the Management of Varicose Veins
A. Cavezzi (Italy)

In co operation with STD PHARMACEUTICAL PRODUCTS

15.30 - 16.00 Lecture

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00

Aspirin Use on a Population Basis
Chairmen: G. Davì (Italy), C. Patrono (Italy)

The Role of Aspirin in Cardiovascular Disease Prevention
C. Patrono (Italy)

The Women’s Healthy Study - Cardiovascular Findings
G. Davì (Italy)

Aspirin Primary Prevention Trials
C. Baigent (UK)

Aspirin and Clopidogrel Resistance
G. Rao (USA)

In co operation with BAYER HEALTHCARE

MONDAY, JUNE 26, 2006 - HALL D

11.30 - 13.00
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/UEMS SECTION OF VASCULAR SURGERY

Vascular Centres and the Training of the Vascular Specialist
Chairmen: F. Benedetti-Valentini (Italy), M. Cairols (Spain), J.J. Belch (UK)

Programme to be defined

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.00 - 15.30

INTERNATIONAL UNION OF ANGIOLOGY/SOCIÉTÉ FRANÇAISE DE MÉDECINE VASCULAIRE

Therapeutic Education in Patients with Vascular Diseases. The French Experience
Chairmen: B. Sandrin-Berthon (France), P. Carpentier (France)

The Paradigm of Therapeutic Education
B. Sandrin-Berthon (France)

“Let’s walk” - An Educational Program for Patients with Peripheral Arterial Diseases
P. Carpentier (France)

Therapeutic Education of Patients with Thrombo-embolic Diseases
P. Léger (France)

Therapeutic Education in Patients with Chronic Venous Diseases
B. Satger (France)

Therapeutic Education in Patients with Lymphoedema
I. Quéré (France)

15.30 - 16.00 Lecture

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/SIDV ITALIAN SOCIETY OF VASCULAR INVESTIGATION

Atheromatous Microembolism: Search of the Sources, Detection of Emboli and Implications for Management
Chairmen: F. Benedetti-Valentini (Italy), D.L. Clement (Belgium)

Carotid Plaques and Cerebral Embolism
C. Liapis (Greece)

Embolism to the Brain during Carotid Stenting and Surgery
B. Gossetti (Italy)

The Embolizing Abdominal Aorta
P.L. Antignani (Italy)

Embolism in Aortic Endografts
G. Biasi (Italy)

Aortic Ulcers
D.L. Clement (Belgium)

Blue Toe Syndrome
P. Poredos (Slovenia)

Renal Microembolism
M. Henry (France)

Multiple Cholesterol Embolization Syndrome
F. Benedetti-Valentini (Italy)

 

MONDAY, JUNE 26, 2006 - HALL F

11.30 - 18.00 Oral Communications

 

EXECUTIVE BOARD ROOM

18.00 - 19.30

Topical Hemostatic Agents: An International Consensus Forum
Under the auspices of Loyola and the International Academy of Clinical and Applied Thrombosis and Hemostasis

Chairmen: J. Fernandes e Fernandes (Portugal), P. Kalman (USA)
Moderator: J. Fareed (USA)

Topical Hemostatic Agents: An Overview
J. Fareed (USA)

Hemostatic Restoration in Patients with Vascular Access
V. Bansal (USA)

Bovine Thrombin as a Universal Topical Hemostatic Agent. Past, Present and Future
H.L. Messmore (USA)

Structure and Function of Thrombins
J. Fenton (USA)

Hemostatic Effects of Bovine Thrombin - PRP Mixtures
L. Clarizio (USA)

Hemostatic Approaches in Surgical and Interventional Practice
R. Wahi (USA)

Newer Approaches to Develop Hemostatic Products
D. Hoppensteadt (USA)

Recombinant Human Thrombin Equivalent Products. Issues Related to Bioequivalence and Immunogenicity
J. Fareed (USA)

Panel Discussion
Controversial issues related to the current and future thrombin derived products

Top

TUESDAY, JUNE 27, 2006 - HALL A

PLENARY SESSION

8.30 - 9.00
Lecture
The 3rd Antonio Strano Lecture
Risk Factors, Vascular Aging and Atherosclerosis
S. Novo (Italy)

9.00 - 11.00

Update on Management of Venous Thromboembolism - From Epidemiology to Prophylaxis
Chairmen: A. Cohen (USA), M. Samama (France)
Alternate Chairmen: A.N. Nicolaides (Cyprus), J. Fletcher (Australia)

Long-term Management of Thromboembolism
M. Samama (France)

Extended Prophylaxis of VTE in Cancer Patients
S. Haas (Germany)

Survival Outcome in VTE Patients Managed with Anticoagulants
A.J. Kakkar (UK)

Post-thrombotic Syndrome and Extended Prophylaxis
R. Hull (Canada)

Need for Registers to Validate Clinical Trials
G. Lowe (UK)

What is New in the Management of VTE
A. Cohen (USA)

Outpatient Management of VTE in Extended Care Setting
R. Hull (Canada)

In co operation with SANOFI AVENTIS

11.00 - 11.30 BREAK AND VISIT OF THE EXHIBITION

11.30 - 13.00

New Frontiers on Medical Management of Peripheral Arterial Occlusive Disease
Chairmen: L. Norgren (Sweden), E. Bastounis (Greece), S. Novo (Italy), A.D. Frankini (Brazil)

Metabolic Therapy
G. Brevetti (Italy)

Inhibition of Serotoninergic Receptors
D.L. Clement (Belgium)

Effects of Antiplatelet Drugs
S. Novo (Italy)

The Effect of Phosphodiesterase Inhibitors
W. Hiatt (USA)

What is the Evidence for Conservative Treatment of PAOD?
H. Rieger (Germany)

Calf Stimulation - Is it an Alternative in PAOD?
E. Kalodiki (UK)

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.00 - 15.30

Heparin-induced Thrombocytopenia
Chairmen: J. Walenga (USA), B. Chong (Australia)
Moderator: Y. Gruel (France)

Pathogenesis of Heparin-induced and Thrombosis
B. Chong (Australia)

Clinical and Laboratory Diagnosis of Heparin-induced Thrombocytopenia
Y. Gruel (France)

Danaparoid as an alternate Management of Heparin-induced Thrombocytopenia
E. Lindhoff-Last (Germany)

Direct Thrombin Inhibitors in the Management of HIT
J. Walenga (USA)

Use of Direct Antithrombin Agents in CABG Patients with HIT
A. Koster (Germany)

HIT in Patients Treated with Heparin-coated Devices Including LVAD
E.V. Potapov (Germany)

Invited Discussion
Heparin-induced Thrombocytopenia. Reflections of the Past 50 Years
H. Messmore (USA)

In co operation with ORGANON

15.30 - 16.00 Lecture

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/INTERNATIONAL UNION OF PHLEBOLOGY

Signs, Symptoms and Quality of Life in CVD
Chairmen: C. Allegra (Italy), E. Rabe (Germany), A. Scuderi (Brazil)

Quality of Life Scores for CVD: What should be used?
J. Bergan (USA)

Health Status of a Population and Care Impact on this Health Status Through Quality of Life Questionnaires
J.J. Guex (France)

The C0s Patients: Are there Specific Signs and Symptoms?
P.L. Antignani (Italy)

 

TUESDAY, JUNE 27, 2006 - HALL B

11.00 - 13.00

Generic Antithrombotic Drug Impact on Clinical Practice
Chairmen: J. Fareed (USA), L. Pathak (India), R. Wahi (USA), V. Maria (Portugal)

Currently Developed Generic Anticoagulants and Antithrombotic Drugs
J. Fareed (USA)

Do we Need New Rules for Generic Antithrombotic Drugs?
P. Bacher (USA)

Generic Heparins and Low Molecular Weight Heparin
W. Jeske (USA)

Generic Antiplatelet Drugs
S. Mousa (USA)

Generic Oral Anticoagulant Drugs
J. Walenga (USA)

Generic Thrombolytic Drugs
A. Sasahara (USA)

Generic Antagonists for Anticoagulant and Thrombolytic Agents
O. Iqbal (USA)

Regulatory Perspective
I. Khan (Switzerland)

Regulatory Consideration
E. Padilla (USA)

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.30 - 16.00
Satellite Symposium

BRISTOL MYERS SQUIBB/SANOFI AVENTIS

New Developments in The Management of Atherothrombotic Risk Associated with Peripheral Arterial Disease
Chairman: C. Diehm (Germany)

Pathophysiology and Risk of Ischemic Events in Patients with Peripheral Arterial Disease
J.J. Belch (UK)

Strategies for Vascular Intervention in Patients with PAOD
J. Olin (USA)

New Insights in the Management of Patients at High-risk of Atherothrombotic Events
P. Cacoub (France)

Translating Clinical Evidence into Real-world Practice
A. Hirsch (USA)

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

14.30 - 16.00
Satellite Symposium

BRISTOL MYERS SQUIBB/SANOFI AVENTIS

New Developments in The Management of Atherothrombotic Risk Associated with Peripheral Arterial Disease
Chairman: C. Diehm (Germany)

Pathophysiology and Risk of Ischemic Events in Patients with Peripheral Arterial Disease
J.J. Belch (UK)

Strategies for Vascular Intervention in Patients with PAOD
J. Olin (USA)


New Insights in the Management of Patients at High-risk of Atherothrombotic Events
P. Cacoub (France)

Translating Clinical Evidence into Real-world Practice
A. Hirsch (USA)

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00

New Frontiers for the Treatment of Critical Limb Ischemia
Chairmen: E. Bastounis (Greece), Sir Peter Bell (UK)

Remote Endarterectomy: A Possibility?
F. Moll (The Netherlands)

Subintimal Angioplasty - Indications and Results
Sir Peter Bell (UK)

Conventional Distal Revascularization
E. Bastounis (Greece)

Pedal Revascularization: Selection, Technique and Outcomes
P. Gloviczki (USA)

Determinants of Success on Surgical Treatment of CLI
J. Fernandes e Fernandes (Portugal)

End-stage Renal Disease and CLI
F. Spinelli (Italy)

What can we Expect from Prostanoids?
V. Riambau (Spain)

TUESDAY, JUNE 27, 2006 - HALL C

11.00 - 11.30 BREAK AND VISIT OF THE EXHIBITION

11.30 - 13.00

CEAP and New Perspectives on the Management of Chronic Venous Disease
Chairmen: C. Allegra (Italy), P.L. Antignani (Italy), B. Eklof (Sweden)

How is CEAP used in the Literature in the Last 5 Years?
P. Coleridge-Smith (UK)

Do we need further Revisions of CEAP?
B. Eklof (Sweden)

What is the Place of Telangiectasia and Corona Phlebectatica in CVD? The Epidemiological Approach
E. Rabe (Germany)

Diagnosis of Venous Symptoms and Venous Reflux
P. Carpentier (France)

Diagnostic Criteria of the Corona Phlebectatica
A. Cornu-Thenard (France)

Correlation of A and P with the C classes of CEAP
J.F. Uhl (France)

What is the Role of Scores?
P.L. Antignani (Italy)

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.00 - 15.30
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/SOCIÉTÉ FRANÇAISE D’ANGÉOLOGIE AND SOCIÉTÉ FRANÇAISE DE PHLÉBOLOGIE

Obesity and Chronic Venous Disorders
Chairmen: F.A. Allaert (France), M. Cazaubon (France)
Moderator: R. Wahi (USA)

BMI and Chronic Venous Disorders
F.A. Allaert (France)

CVD in Obese Men: Results of an Epidemiological Study
J.P. Benigni (France)

What Compression in Obese with CVD?
E. Rabe (Germany)

Abdominal Hyperpressure, Obesity and Venous Diseases
B. Eklof (Sweden)

The Place of the Surgery of Obesity
J. Cady (France)

In co operation with LABORATOIRES INNOTHERA

15.30 - 16.00 Lecture

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00

Non Cardiac Vascular Disease in Women: Same Disease, Different Issues
Chairmen: A. Balbarini (Italy), P. Kalman (USA)
Moderator: D. Hoppensteadt (USA)

Cardiovascular Health and Disease in Women: Problems and Prospects
D.L. Clement (Belgium)

Sex Differences in Peripheral Arterial Disease
G. Brevetti (Italy)

Sex Differences in Carotid Artery Disease
S. Novo (Italy)

Abdominal Aortic Aneurysm - Differences in Women
P. Kalman (USA)

TUESDAY, JUNE 27, 2006 - HALL D

11.30 - 13.00
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/AUSTRIAN SOCIETY OF VASCULAR MEDICINE

Endovascular Revascularisation - What’s the News
Chairmen: K.L. Schulte (Germany), E. Pilger (Austria)

Stenting of SFA - When is it Appropriate?
K.L. Schulte (Germany)

EVR in the Lower Limb
M. Brodmann (Austria)

EVR in Critical Limb Ischemia - The First Choice
D. Scheinert (Germany)

Stenting of CFA and PA - A don’t?
E. Pilger (Austria)

In co operation with GUIDANT

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

14.00 - 15.30
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/WORKING GROUP OF THE EUROPEAN SOCIETY OF CARDIOLOGY ON PERIPHERAL CIRCULATION

New Insights in Prevention and Treatment of PAD
Chairmen: D.L. Clement (Belgium), S. Novo (Italy), P. Poredos (Slovenia)

Cardiovascular Risk Assessment in PAD
Z. Fras (Slovenia)

The Rationale for using Antiplatelets
A. Blinc (Slovenia)

The Role of Statins in the Evaluation of PAD and Prevention of Cardiovascular Events
D. Mikhailidis (UK)

Treatment of Hypertension
D.L. Clement (Belgium)

Is Surgical Revascularization Indicated in Intermittent Claudication?
L. Norgren (Sweden)

15.30 - 16.00 Lecture

16.00 - 16.30 BREAK AND VISIT OF THE EXHIBITION

16.30 - 18.00
Joint Symposium

IUA/ISL-LMC/g.e.l INTERNATIONAL SOCIETY OF LYMPHOLOGY-LATIN MEDITERRANEAN CHAPTER/EUROPEAN LYMPHOLOGY GROUP

Advances in the Management of Lymphoedema
Chairmen: B.B. Lee (USA), M. Andrade (Brazil), P. Bourgeois (Belgium), C. Campisi (Italy)

Classification, Staging and Diagnosis
M. Andrade (Brazil)

Lymphoscintigraphy
P. Bourgeois (Belgium)

Lymphatic Malformations
B.B. Lee (USA)

ISL Consensus Document and National/Regional Guide Lines
C. Campisi (Italy)

Lymphoedema - Angiodysplasias Syndromes
M. Witte (USA)

Pathophysiology and Immune Reaction
W. Olszewski (Poland)

Conservative Therapy of Lymphoedema
E. Foeldi (Germany)

Elephantiasis of External Genitalia
H. Guedes (Brazil)

Lymphatic Microsurgery and Aspects of Prevention
F. Boccardo, S. Michelini (Italy)

TUESDAY, JUNE 27, 2006 - HALL E

11.30 - 13.00
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/ISTF INTERNATIONAL SURGICAL THROMBOSIS FORUM

Mechanical Versus Chemical Thromboprophylaxis
Chairmen: A.K. Kakkar (UK), O.E. Dahl (UK)
Moderator: J. Fletcher (Australia)

The Rationale of Compression
V.V. Kakkar (UK)

Mechanical Compression Methods
D. Warwick (UK)

Anticoagulants, Benefits and Drawbacks
J. Fletcher (Australia)

Mechanical and/or Chemical Thromboprophylaxis?
D. Bergqvist (Sweden)

The Combination of Physical and Pharmacological Prophylaxis in General Surgical Patients
J. Caprini (USA)

Compression for the Prevention and Management of Post-thrombotic Syndrome
J.I. Arcelus (Spain)

Primary and Secondary Indications for Mechanical Devices
M. Lassen (Denmark)

Closing remarks
A.K. Kakkar (UK)

13.00 - 14.00 LUNCH BREAK AND POSTER VISIT

HALL F

11.30 - 18.00 Oral Communications

 
Top

WEDNESDAY, JUNE 28, 2006 - HALL A

PLENARY SESSION

8.30 - 9.00
Lecture
Molecular and Cellular Pathogenesis of Neurodegenerative Diseases and Vascular Dementia
J. Lee (USA)

9.00 - 10.30

TASC II
Chairmen: W. Hiatt (USA), S. Novo (Italy), L. Norgren (Sweden)

Introduction: “From TASC to TASC II”
L. Norgren (Sweden)

What’s New in PAD Epidemiology?
J. Dormandy (UK)

New Insights into Intermittent Claudication
W. Hiatt (USA)

Critical Limb Ischemia: Has the Frontier of Treatment Advanced?
L. Norgren (Sweden)

Acute Ischemia, the Modern Approach
M. Nehler (USA)

The Choice of Endovascular or Open Revascularization
K. Harris (UK)

How to Proceed with the TASC II Project?
W. Hiatt (USA)

In co operation with BRISTOL MYERS SQUIBB/SANOFI AVENTIS

10.30 - 11.00 BREAK AND VISIT OF THE EXHIBITION

11.00 - 11.30 Lecture

11.30 - 13.00
Thrombophilia: New Aspects for Diagnosis and Management
Chairmen: R.L. Bick (USA), A. Mansilha (Portugal), M. Demir (Turkey)

Thrombophilias and their Impact on Thrombosis
R.L. Bick (USA)

Molecular Thrombophilia
A.N. Nicolaides (Cyprus)

Drug Induced Thrombophilia
R. Saxena (India)

Pharmacogenomics of Anticoagulant Drugs
O. Iqbal (USA)

Molecular Thrombophilia is not Associated with Cancer Mediated Thrombosis
D. Hoppensteadt (USA)

Laboratory Methods for the Diagnosis of Molecular Thrombophilias
M. Demir (Turkey)

13.00 - 13.20 End of the Congress - Closing Remarks

WEDNESDAY, JUNE 28, 2006 - HALL B

11.00 - 11.30 Lecture

11.30 - 13.00
Acute Coronary Syndrome, Vulnerable Plaque and Peripheral Arterial Disease
Chairmen: L. Pathak (India), J. Fernandes e Fernandes (Portugal)
Moderator: N. Kipshidze (USA)

Pathophysiology of Vulnerable Plaque and ACS
S. Novo (Italy)

Vulnerable Plaque or Vulnerable Patient
M. Naghavi (USA)

Catheter Based Diagnosis
C. Stefanadis (Athens)

Controversies is Disease Management in Patients with PVD
J.J. Belch (UK)

Medical Therapy: Emerging Pharmacology
J. Fareed (USA)

Surgeon’s Perspective
M. Antunes (Portugal)

Interventional Treatment
N. Kipshidze (USA)

WEDNESDAY, JUNE 28, 2006 - HALL C

11.00 - 11.30 Lecture

11.30 - 13.00
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/CEVF CENTRAL EUROPEAN VASCULAR FORUM

Atherosclerosis-systemic, Disease-systemic Approach
Chairmen: L. Norgren (Sweden), K. Roztocil (Czech Republic)

Atherogenetic Mechanisms and Morphologic Characteristic of Atherosclerotic Lesions in Different Locations - Are they Identical?
S. Novo (Italy)

Do Preclinical Markers of Atherosclerosis Predict Systemic Disease?
M. Sabovic (Slovenia)

Screening for Atherosclerotic Disease
A.N. Nicolaides (Cyprus)

Multifocal Atherosclerotic Diseases and the Risk for Cardiovascular Events
M. Kozak (Slovenia)

Do Preventive Measures depend on Location of Atherosclerotic Process?
P. Poredos (Slovenia)

Invasive Access to the Patient with Multifocal Atherosclerosis
J. Fernandes e Fernandes (Portugal)

Inflammatory and Dysmetabolic Parameters in Patient with PAOD: An Observational Study
A. Carlizza (Italy)

 

WEDNESDAY, JUNE 28, 2006 - HALL D

11.00 - 11.30 Lecture

11.30 - 13.00
Joint Symposium

INTERNATIONAL UNION OF ANGIOLOGY/NORTH AFRICAN AND NORTH AMERICAN CHAPTER OF THE IUA

New Horizons in Anticoagulants, Antithrombotics and Thrombolytics
Chairmen: D. Hoppensteadt (USA), A. Salama (Egypt)

What’s New in Anticoagulation
J. Fareed (USA)

Catheter-directed Lower Limbs Intra Arterial Thrombolysis - Can we push the Limits?
E. Hussein (Egypt)

Statins and Thrombogenesis
J. Fenton (USA)

New Horizons in Antithrombotics
M. Mousa (USA)

Statins in the Control of Thrombogenesis. The Missing Link
J. Fenton (USA)

HALL F

11.30 - 13.00 Oral Communications

 
Top
   

LECTURES

Microcirculation and Investigation Laboratory: Clinical or Research Use?
C. Allegra (Italy)

Vascular Manifestations of End Stage Renal Disease
V. Bansal (USA)

Heparins and Low Molecular Weight Heparins. My Adventure for the Past 50 Years
P. Bianchini (Italy)

Acute Ischemia of Lower Limbs: Endovascular Therapy
M. Bulvas (Czech Republic)

Risk Assessment as a Guide to Thrombosis Prophylaxis
J. Caprini (USA)

New Developments of the Semiology of Chronic Venous Disorders: From the Diagnosis of Venous Symptoms to the Clinimetry of Trophic Changes
P. Carpentier (France)

Defibrotide: New Concepts and Results for an Unconventional Antithrombotic Agent
S. Coccheri (Italy)

Pharmacomechanical Venous Thrombectomy for Extensive DVT
A. Comerota (USA)

Endovascular Treatment of Thoracic Aorta Aneurysms
G. Deriu (Italy)

Minimally Invasive (not Endovascular) Aortic Surgery
G. de Donato (Italy)

Advances on Anticoagulant and Anti-thrombotic Treatments
J. Fareed (USA)

Vascular Manifestations of Depression
A. Halaris (USA)

Can Endovascular Surgery Alter the Course of CLLI?
E. Hussein (Egypt)

Cancer and Thrombosis
A.J. Kakkar (UK)

Endovascular Management of Vascular Disorders
P. Kalman (USA)

The Use of Intermittent Pneumatic Compression in the Treatment of Venous Ulcers
E. Kalodiki (UK)

Drug Eluting Grafts in Vascular Surgery
N. Kipshidze (USA)

Molecular and Cellular Pathogenesis of Neurodegenerative Diseases and Vascular Dementia
J. Lee (USA)

Follow up after Venous Thrombosis
A. Markel (Israel)

Safe Exclusion of Deep Vein Thrombosis (DVT) by a Normal Rapid ELISA D-dimeer (< 500 ng/ml) and by the Combination of a Negative Compression Ultrasonography and a D-Dimer of <1000 ng/ml in 1330 Consecutive Outpatients with Suspected DVT in the Primary Care Setting
J.J. Michiels (The Netherlands)

Key Frontiers in Angiogenesis Modulation: Implications in Vascular Disorders
S. Mousa (USA)

Atherosclerosis Aging and the Challenge of the Future?
S. Novo (Italy)

C-reactive Protein and other Biomarkers of Inflammation Effects on Atherosclerosis
R. Paoletti (Italy)

Challenges for the Vascular Surgeon after Endovascular Treatment
W. Sandmann (Germany)

N.B. The content and schedule of the scientific programme may be subject to further changes.